Chemo Healthcare Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 22-06-2024
- Paid Up Capital ₹ 0.95 M
as on 22-06-2024
- Company Age 20 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 7.26%
(FY 2023)
- Profit 95.18%
(FY 2023)
- Ebitda 37.58%
(FY 2023)
- Net Worth 44.47%
(FY 2023)
- Total Assets 6.18%
(FY 2023)
About Chemo Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 0.95 M, as per Ministry of Corporate Affairs (MCA) records.
Babu Ostawal and Amit Ostawal serve as directors at the Company.
- CIN/LLPIN
U85110GJ2004PTC044341
- Company No.
044341
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jun 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Chemo Healthcare Private Limited offer?
Chemo Healthcare Private Limited offers a wide range of products and services, including Common Disease Medicines, Antihistamines, Cardiovascular Drugs & Medication, Blood Pressure Medicine, Anti Acne Drug, Pharmaceutical Capsules, Pharmaceutical Tablets, Levocetirizine Dihydrochloride Montelukast Tablet, Pharmaceutical Medicine, Film Coated Tablets.
Who are the key members and board of directors at Chemo Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Ostawal  | Director | 21-Jun-2004 | Current |
| Babu Ostawal | Director | 15-Oct-2016 | Current |
Financial Performance of Chemo Healthcare.
Chemo Healthcare Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.26% increase. The company also saw a substantial improvement in profitability, with a 95.18% increase in profit. The company's net worth Soared by an impressive increase of 44.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chemo Healthcare?
In 2023, Chemo Healthcare had a public holding of 0.11%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chemo Healthcare?
Unlock and access historical data on people associated with Chemo Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemo Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemo Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
